التفاصيل البيبلوغرافية
| العنوان: |
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study |
| المؤلفون: |
Wong, Ka Sing1 ks-wong@cuhk.edu.hk, Chen, Christopher2, Ng, Ping Wing3, Tsoi, Tak Hong4, Li, Ho Lun5, Fong, Wing Chi6, Yeung, Jonas7, Wong, Chi Keung8, Yip, Kin Keung9, Gao, Hong10, Wong, Hwee Bee10, FISS-tris Study Investigators (CORPORATE AUTHOR) |
| المصدر: |
Lancet Neurology. May2007, Vol. 6 Issue 5, p407-413. 7p. |
| مصطلحات موضوعية: |
*CEREBROVASCULAR disease patients, *ASPIRIN, *ANALGESICS, *ANTICOAGULANTS, *CENTRAL nervous system depressants |
| مستخلص: |
Summary: Background: Acute stroke patients with large artery occlusive disease (LAOD) have a distinct pathophysiology and may respond differently to anticoagulation treatments. We compared the efficacy of a low-molecular-weight heparin (LMWH), nadroparin calcium, with aspirin in Asian acute stroke patients with LAOD. Methods: Acute ischaemic stroke patients with onset of symptoms less than 48 h and LAOD (diagnosed by transcranial doppler imaging, carotid duplex scan, or magnetic resonance angiography) were recruited. Patients were randomly assigned to receive either subcutaneous nadroparin calcium 3800 anti-factor Xa IU/0·4 mL twice daily or oral aspirin 160 mg daily for 10 days, and then all received aspirin 80–300 mg once daily for 6 months. This study is registered at www.strokecenter.org/trials (number 493). Findings: Among 603 patients recruited, 353 (180 LMWH, 173 aspirin) had LAOD (300 had intracranial LAOD only, 42 had both intracranial and extracranial disease, and 11 had extracranial disease only). The proportion of patients with good outcomes at 6 months (Barthel index ≥85) was 73% in the LMWH group and 69% in the aspirin group (absolute risk reduction 4%; 95% CI −5 to 13). Analysis of prespecified secondary outcome measures showed a benefit in outcome for LMWH versus aspirin on the modified Rankin scale dichotomised at 0–1 (odds ratio 1·55, 95% CI 1·02–2·35). Haemorrhagic transformation of infarct and severe adverse events were similar in both groups. Post-hoc analyses of patients without LAOD, and all treated patients, showed similar proportions with a good outcome in aspirin and LMWH groups (78%vs 79% and 73%vs 75%, respectively). Interpretation: Overall, the results do not support a significant benefit of LMWH over aspirin in patients with LAOD. The benefits indicated in most outcome measures warrant further investigation into the use of anticoagulation for acute stroke in patients with large artery atherosclerosis, particularly in intracranial atherosclerosis. [Copyright &y& Elsevier] |
| قاعدة البيانات: |
Academic Search Index |
